The company's investment in diagnostics firm Recipe is part of an effort to develop its DART mass spec tech for therapeutic drug monitoring and drugs of abuse testing.

The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Last week, readers were most interested in a story about how the FDA could exert authority over LDTs in the future.

Labcorp also becomes a referral lab for the system's seven hospitals and clinical labs and will open three new patient service centers.

The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease ...

VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases ...

The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.

NEW YORK – With the UK launch of its combination PCR and immunoassay testicular cancer test last week, EDX Medical said that its test could improve the detection of early-stage cancers in young men as ...

NEW YORK – Agilent Technologies said Thursday that it has gained expanded certification under the EU's In Vitro Diagnostic Regulation for the use of its PD-L1 companion diagnostic test to aid ...

The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.